Clinical Trials Directory

Trials / Completed

CompletedNCT02082314

Prospective Study Determining the Pain Response, Functional Interference and Quality of Life in Patients Undergoing Radiofrequency Ablation Assisted Vertebroplasty/ Cementoplasty

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
Sunnybrook Health Sciences Centre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Bone metastases are a cause of significant morbidity in cancer patients. In patients who die from breast, prostate, and lung cancer, autopsy studies have shown that up to 85% have evidence of bone metastases at the time of death (1). These metastases frequently give rise to complications that reduce patients' quality of life. These include: pain, fractures, and decreased mobility, ultimately reducing performance status. Radiofrequency ablation therapy with cementoplasty/vertebroplasty for painful bone metastases has been shown to be feasible, efficacious, and safe. However, patient reported outcomes have yet to be determined.

Conditions

Interventions

TypeNameDescription
PROCEDURERFA Vertebroplasty

Timeline

Start date
2014-02-01
Primary completion
2016-04-01
First posted
2014-03-10
Last updated
2016-10-14

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02082314. Inclusion in this directory is not an endorsement.